Gaudium IVF and Women Health made a positive debut on the stock exchanges on February 27, with the stock listing at a premium to its issue price.
Gaudium IVF and Women Health made a positive debut on the stock exchanges on February 27, with the stock listing at a premium to its issue price.
The fertility services provider debuted at Rs 83 apiece on both the NSE and the BSE, a premium of 5.06 per cent over the issue price of Rs 79 per share. In absolute terms, the stock opened Rs 4 higher than the price at which shares were allotted in the IPO.
Ahead of the listing, shares of Gaudium IVF and Women Health were quoting a nil grey market premium (GMP) in the run-up to the debut, according to websites that track such trades, suggesting expectations of a flat-to-marginal listing.
The company had offered its shares in a price band of Rs 75 to Rs 79 apiece. Investors were required to bid for a minimum lot of 189 shares. At the upper end of the band, retail investors had to commit at least Rs 14,931 for one lot.
With the stock listing at Rs 83, retail investors who received allotment earned a notional gain of Rs 756 per lot at the time of listing.
This is a developing story...